Literature DB >> 32927039

Long-Term Outcomes after Thoracic Endovascular Aortic Repair Using Chimney Grafts for Aortic Arch Pathologies: 10 Years of Single-Center Experience.

Wael Ahmad1, Oliver J Liakopoulos2, Spyridon Mylonas3, Moritz Wegner3, Jan Brunkwall3, Bernhard Dorweiler3.   

Abstract

BACKGROUND: This study reports the early- and long-term outcomes of the thoracic endovascular aortic repair using the Chimney-Graft technique (ChTEVAR) for the treatment of aortic arch pathologies.
METHODS: From January 2010 to December 2019, patients who underwent aortic ChTEVAR technique in our institution were included. Early, mid, and long-term outcomes in this group of patients were evaluated. Patient follow-up data were obtained by imaging follow-up that are routinely performed after 3-6 months following initial surgery and then at yearly intervals.
RESULTS: Aortic arch repair with a ChTEVAR was performed in 54 patients. The 30-day mortality was 18.5% (n = 10). All-cause 30-day mortality was higher in the subgroup of patients operated urgently (33% vs. 14%) without a significant difference (P = 0.141). Permanent neurological deficit (PND) was observed in 15% (8/54 patients); stroke in 11% (6/54), and paraplegia 4% (2/54). During follow-up the primary and primary-assisted chimney-graft patency was 96.8% and 97.8%, respectively. The multivariate analysis identified the age >70 years and the aortic diameter as independent risk factors for elevated mortality during the follow-up (P = 0.015 and 0.001, respectively). The PND was an independent predictor for 30-day mortality (P = 0.014, hazard ratio 13.5, 95% confidence interval 1.7-106.6).
CONCLUSIONS: The ChTEVAR has noninferior results to other open and endovascular aortic arch repair methods with an acceptable long-term survival especially in elective procedures.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Year:  2020        PMID: 32927039     DOI: 10.1016/j.avsg.2020.08.129

Source DB:  PubMed          Journal:  Ann Vasc Surg        ISSN: 0890-5096            Impact factor:   1.466


  3 in total

1.  First-in-Human Implantation of Gutter-Free Design Stent-Graft in in situ Fenestration TEVAR for Aortic Arch Pathology.

Authors:  Xin Li; Chang Shu; Lunchang Wang; Quanming Li; Kun Fang; Mingyao Luo; Weichang Zhang; Yang Zhou; Haiyang Zhou
Journal:  Front Cardiovasc Med       Date:  2022-06-30

Review 2.  Type 1A Endoleak after TEVAR in the Aortic Arch: A Review of the Literature.

Authors:  Lucia Scurto; Nicolò Peluso; Federico Pascucci; Simona Sica; Francesca De Nigris; Marco Filipponi; Fabrizio Minelli; Tommaso Donati; Giovanni Tinelli; Yamume Tshomba
Journal:  J Pers Med       Date:  2022-08-04

3.  Commentary: Thoracic endovascular aortic arch repair using custom made endografts: A good alternative to open repair?

Authors:  Wael Ahmad; Oliver J Liakopoulos
Journal:  JTCVS Tech       Date:  2020-10-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.